Cargando…

Left atrial fibrosis in atrial fibrillation: Mechanisms, clinical evaluation and management

Atrial fibrillation (AF), the commonest arrhythmia, shows associations with various disease conditions. Mounting evidence indicates that atrial fibrosis is an important part of the arrhythmogenic substrate, with an essential function in the generation of conduction abnormalities that underlie the tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Jin, Chen, Qiuxiong, Ma, Shiyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957273/
https://www.ncbi.nlm.nih.gov/pubmed/33576189
http://dx.doi.org/10.1111/jcmm.16350
_version_ 1783664621200080896
author Ma, Jin
Chen, Qiuxiong
Ma, Shiyu
author_facet Ma, Jin
Chen, Qiuxiong
Ma, Shiyu
author_sort Ma, Jin
collection PubMed
description Atrial fibrillation (AF), the commonest arrhythmia, shows associations with various disease conditions. Mounting evidence indicates that atrial fibrosis is an important part of the arrhythmogenic substrate, with an essential function in the generation of conduction abnormalities that underlie the transition from paroxysmal to persistent AF, which in turn contributes to AF perpetuation. Left atrial (LA) fibrosis is considered a possible major factor and predictor in AF treatment. The present review provides insights into LA fibrosis’ association with AF. The information is focused on clinical aspects and mechanisms, clinical evaluating methods that evaluate fibrosis changes and examining possible options for the prevention of atrial fibrosis.
format Online
Article
Text
id pubmed-7957273
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-79572732021-03-19 Left atrial fibrosis in atrial fibrillation: Mechanisms, clinical evaluation and management Ma, Jin Chen, Qiuxiong Ma, Shiyu J Cell Mol Med Reviews Atrial fibrillation (AF), the commonest arrhythmia, shows associations with various disease conditions. Mounting evidence indicates that atrial fibrosis is an important part of the arrhythmogenic substrate, with an essential function in the generation of conduction abnormalities that underlie the transition from paroxysmal to persistent AF, which in turn contributes to AF perpetuation. Left atrial (LA) fibrosis is considered a possible major factor and predictor in AF treatment. The present review provides insights into LA fibrosis’ association with AF. The information is focused on clinical aspects and mechanisms, clinical evaluating methods that evaluate fibrosis changes and examining possible options for the prevention of atrial fibrosis. John Wiley and Sons Inc. 2021-02-11 2021-03 /pmc/articles/PMC7957273/ /pubmed/33576189 http://dx.doi.org/10.1111/jcmm.16350 Text en © 2021 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Reviews
Ma, Jin
Chen, Qiuxiong
Ma, Shiyu
Left atrial fibrosis in atrial fibrillation: Mechanisms, clinical evaluation and management
title Left atrial fibrosis in atrial fibrillation: Mechanisms, clinical evaluation and management
title_full Left atrial fibrosis in atrial fibrillation: Mechanisms, clinical evaluation and management
title_fullStr Left atrial fibrosis in atrial fibrillation: Mechanisms, clinical evaluation and management
title_full_unstemmed Left atrial fibrosis in atrial fibrillation: Mechanisms, clinical evaluation and management
title_short Left atrial fibrosis in atrial fibrillation: Mechanisms, clinical evaluation and management
title_sort left atrial fibrosis in atrial fibrillation: mechanisms, clinical evaluation and management
topic Reviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957273/
https://www.ncbi.nlm.nih.gov/pubmed/33576189
http://dx.doi.org/10.1111/jcmm.16350
work_keys_str_mv AT majin leftatrialfibrosisinatrialfibrillationmechanismsclinicalevaluationandmanagement
AT chenqiuxiong leftatrialfibrosisinatrialfibrillationmechanismsclinicalevaluationandmanagement
AT mashiyu leftatrialfibrosisinatrialfibrillationmechanismsclinicalevaluationandmanagement